RecruitingPhase 2NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Sponsor: Amgen
Cleveland, OH · +15 more sites
3 recruiting rheumatoid arthritis studies with a site in Cleveland, OH.
All trials in Cleveland, OH · All Rheumatoid Arthritis trials
Sponsor: Amgen
Cleveland, OH · +15 more sites
Sponsor: University of Alabama at Birmingham
Cleveland, OH · Liberty Township, OH · +45 more sites
Sponsor: Duke University
Akron, OH · Cincinnati, OH · Cleveland, OH · +72 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.